Under AI's Lens: Spotting Mutations Visually
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Dohner H, Wei A, Appelbaum F, Craddock C, DiNardo C, Dombret H
. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022; 140(12):1345-1377.
DOI: 10.1182/blood.2022016867.
View
2.
Senapati J, Urrutia S, Loghavi S, Short N, Issa G, Maiti A
. Venetoclax abrogates the prognostic impact of splicing factor gene mutations in newly diagnosed acute myeloid leukemia. Blood. 2023; 142(19):1647-1657.
DOI: 10.1182/blood.2023020649.
View
3.
Khoury J, Solary E, Abla O, Akkari Y, Alaggio R, Apperley J
. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia. 2022; 36(7):1703-1719.
PMC: 9252913.
DOI: 10.1038/s41375-022-01613-1.
View
4.
Venugopal S, DiNardo C, Loghavi S, Qiao W, Ravandi F, Konopleva M
. Differential prognostic impact of RUNX1 mutations according to frontline therapy in patients with acute myeloid leukemia. Am J Hematol. 2022; 97(12):1560-1567.
DOI: 10.1002/ajh.26724.
View
5.
Fu Y, Jung A, Torne R, Gonzalez S, Vohringer H, Shmatko A
. Pan-cancer computational histopathology reveals mutations, tumor composition and prognosis. Nat Cancer. 2022; 1(8):800-810.
DOI: 10.1038/s43018-020-0085-8.
View